BROOKLANDS MEDICAL SUPPLIESTotal Infection Control

“Millions of Americans are harmed every year by medical errors and healthcare acquired infections that are preventable. The new healthcare reform law will save lives and dollars by... leveraging federal health care dollars to give hospitals a stronger incentive to prevent needless suffering and deaths.”

Lisa McGiffert, Director, Consumers Union Safe Patient Project

Corporate Overview - GlobalAPPROVED FOR USE

2

W

E SAVE LIVES

Advanced Biocide Technology Solutions™ (ABTS™)

With the advent of deadly pathogens, bacteria, fungi

and mold affecting populations world wide, Brooklands

Medical Supplies, in partnership with manufacturers

around the world, has produced the world’s most

Advanced Biocide Technology Solutions™.

Our solution uses the most advanced single chemical

compound that produces a seamless protection from

materials to liquids, to human contact to take full

advantage of advanced pathogen destruction. This

global advance brings the ability to accommodate

any requirement in any environment where pathogen

destruction demands a complete solution.

After detailed clinical trials by Campden BRI, two years

of successful use in over 250 hospitals, by UK and

Irish governments and distributed into the UK, China,

Ireland and Germany, Advanced Biocide Technology

Solutions™ are now being released through

Brooklands Medical Supplies to the general population

worldwide.

All BMS ABTS™ products are effective where:

1. Products made of traditional linens are proven to

have high levels of live Pathogens, Bacteria, Fungi

and Molds, that cause human harm or death.1

2. Products known to be in environments where

pathogens, mold or bacteria may be present with a

risk of human contact.

3. Environments where Pathogens, Bacteria, Fungi and

Molds are in direct or indirect contact with humans.

4. Areas where specific activities require custom

development for government and medical safety

environments world wide.

Advanced

3

W

E SAVE LIVES

Conventional versus

Advanced Biocide Technology Solutions™

Conventional linens or plastics wiThOUT inhibitor

technology have been used in the hospital environment for

many years and only recently have been shown as a cause

for hospital acquired infections1.

The introduction of ABTS™ reduces the risk to patients, staff

and visitors of hospital acquired infections by eliminating

99.99999% of pathogens, molds and fungi that come into

contact with the ABTS™2.

Cost Efficiency

in most cases ABTS™ offers a considerable cost saving when

compared to conventional systems:

• Save lives

• Save the planet

• Save on clinical costs

• Save on litigation costs

• Save on infection treatment costs

• Save on labor costs

• Save on laundry costs

• Save on capital costs

Efficient

4

W

E SAVE LIVES

Brooklands at the heart of environmental infection

prevention and control

The heart of the tragedy is that many of the 99,000 annual

deaths in U.S. hospitals resulting from hAis are preventable.

while there are many niche vendors with excellent products

that deal with portions of the environment of care, none

provide a consistent, focused approach tackling the problem

across all environmental sources. Brooklands’ BioGuard™,

the core element of our Advanced Biocide Technology

Solutions™, encompasses the entire environment of care.

Brooklands BioGuard™ products replace traditional and

disposable patient privacy curtains, window curtains, shower

curtains, surface wipes, concentrate for floors, foam and

hand lotions, apparel, covers for beds, pillows, personal

masks, hand rails and paints with advance pathogen killing

biotechnology products built within new fabrics and

liquid technologies. A combination of some or all of these

products are needed in every hospital to provide the “circle

of protection” to aid talented providers deliver the safest

environment for their patients and staff.

By consulting with our customers together we

calculate the cost efficiency of applying BMS

solutions per bed, per procedure, per stay or per

organization.

Regulatory Approval

Brooklands Medical Supplies works closely with all regulatory

bodies worldwide to meet or exceed the necessary

approvals and registrations for our products:

Prevention

A P P R O V E D

A P P R O V E D

A P P R O V E D

N99 & P100 RATINGRULE 42 CFR PART 84

N99 & P100 APPROVED

N99& P100 APPROVED

DCCLGLOBAL PATENT HOLDER.Patent UK GB2441907

int PCT/GB2007/004084

5

W

E SAVE LIVES

Brooklands Circle of Protection

Our circle of protection illustrates all the areas of patient,

staff and enviromental protection afforded by the BioGuard

family of products.

Protection

BioGuard™ BioGuard™

BioGuard™ BioGuard™ BioGuard™ BioGuard™

BioGuard

™ Bi

oGua

rd™

BioGuard™ BioGuard™

Recycle

Liquids

Surfaces

Apparel

Bedding

PaintsWashes

Fabrics

IT

RespiratorsAir

Equipment

6

W

E SAVE LIVES

The Biocide

Brooklands Medical Supplies use a biocide containing the

active ingredient of Didecyl Dimethyl Ammonium Chloride

(DDAC) combined with Polypropylene in various levels of

strength to build ABTS™.

DDAC is a low level disinfectant from the chemical class of

Quaternary Ammonium Compound (QAC, QUATS) that has

the relevant information.

Chemical Abstract Number (CAS): 7173-51-5

FDA listing number D095479

US EPA PC CODE: 069149

CA DPR Chem Code: 1682

Use Type: Fungicide

Microbiocide

Efficacy

The QAC used on Brooklands Medical Supplies products are

99.99999% effective against the following but are not limited

to those listed opposite:

Biotechnology

7

W

E SAVE LIVES

Control

Bacteria

Community-associated methicillin resistant staphylococcus aureus (CA-MRSA) m s

Enterobacter aerogenes m s

Enterococcus hirae m s

Escherichia coli (O157) m s

Molds - Yeasts

Aspergillus niger m s

Candida albicans m s

Cladosporium cladosporiodes m s

Algae

Chlorella vulgaris m s

Viruses

Adenovirus Type 3 s

Bovine Rhinotracheitis s

Canine Distemper s

Coronavirus (SARS) s

Hepatitis B s

Bacteria

Klebsiella spp. s

Klebsiella pneumoniae s

Legionella pneumophila m s

Listeria monocytogenes m s

Proteus penneri s

Microsporum canis m s

Penicillium glaucum m s

Penicillium funiculosum m s

Nostoc commune m s

Hepatitis C s

Herpes simplex s

HIV-1 (AIDS) s

Influenza s

Measles s

Bacteria

Pseudomonas aeruginosa m s

Salmonella enteritidis s

Staphylococcus aureus s

Staphylococcus aureus (MRSA) m s

Vancomycin-resistant enterococcus (VRE) m s

Saccaromyces cerevisiae m s

Trichophyton mentagrophytes m s

Scenedesmus vacuolatus m s

Newcastle Disease s

Parvovirus s

Rabies s

Rubella s

8

W

E SAVE LIVES

The Efficacy of Advanced Biocide Technology Solutions™

The antimicrobial activity of polypropylene materials

tested and treated with DCCL Biocidal Treatment - DCCL 23

(Fh/116479/3), 6 month old (used) materials treated with

DCCL Biocidal Treatment (Fh/116479/1 and Fh/116479/2)

and untreated (no biocide) materials (Fh/116479/6) were

assessed against methicillin resistant Staphylococcus aureus

(MRSA), Vancomycin Resistant Enterococcus faecium (VRE)

and Escherichia coli, using a modified Kirby Bauer test.2

Polypropylene materials tested and treated with DCCL

Biocidal Treatment - DCCL 23 (Fh/116479/3) had an

antibacterial effect against MRSA, VRE and E. coli with zones

of clearing visible around all of the test samples.2

Quaternary Ammonium Cations

Quaternary ammonium cations, also known as

quats, are positively charged polyatomic ions

of the structure NR4+, R being an alkyl group.

Unlike the ammonium ion (Nh4+) and the

primary, secondary, or tertiary ammonium

cations, the quaternary ammonium cations are permanently

charged, independent of the ph of their solution. Quaternary

ammonium salts or quaternary ammonium compounds

(called quaternary amines in oilfield parlance) are salts of

quaternary ammonium cations with an anion.

Evidence

MRSAZone of inhibition

5-10mm

VREZone of inhibition

3-7mm

E. ColiZone of inhibition

2-4mm

ControlZone of inhibition

0mm

TREATED MATERiAL wiTh ABTS™UNTREATED

9

W

E SAVE LIVES

The Law of Attraction

A biostatic agent inhibits further growth of a microorganism

without killing it. As long as the microorganism is exposed

to the biostatic agent, biostatic fabric or biostatic fiber, the

microorganism will not be able to proliferate. Brooklands

biostatic formulations are water stabilized allowing for safe

residential and commercial use.

with our Advanced Biocide Technology Solutions™ the

effect is two fold, the biostatic traps the pathogen and

the biocidal agent pierces the cell, preventing cross

contamination.

Efficacy

10

W

E SAVE LIVES

Application

Applications for ABTS™

Although primarily developed for the hospital and

healthcare market Brooklands BioGuard is also relevant in

the following industries

healthcare

Privacy curtains

window curtains

Shower curtains

Surgical scrubs and gowns

Bedding

Seat covers

hand wash

Alcohol free cleaning wipes

Laboratory

Lab coats

Lab suits

hats

Over boots

Military

hospital tents

Tent liners

Shower and toilet tents

Apparel

Disaster relief

Accommodation tents

hospital tents

Shower and toilet tents

Overalls

Space exploration

Space apparel

hospitality

window treatments

Shower curtains

Privacy curtains

11

W

E SAVE LIVES

Key Performance indicators

Advanced Biocide Technology Solutions™ have been

developed to create a “BioShield” that is integrated into

everyday products and work in environments where

pathogen risks are of a concern:

BiOCiDE (liquid - based on 7 day protocol)

• A biodegradable biocide which forms an invisible biostatic

and biocidal layer on each product/surface

• Offers a 5 log kill rate 7 days after application

• Patient kits have 5 log kill rate against C. Difficile

(vegetative, h5N1, Avian Flu, Coronavirus (SARS) and

proven to have sporadical activity against C. Difficile

spores EN 13704)

BiOCiDE (fabric - based on protocol at 1%)

• Bacteria cannot penetrate the surface and are inhibited/

killed within 30 seconds

• Residual Biocide is proven to be effective for 6 months

but can last as long as 12 months.

• 5 log kill rate against Enterococcus hirae, Escherichia

coli, Listeria monocytogenes, Pseudomonas aeruginosa,

Methicillin-resistant Staphylococcus aureus (MRSA) and

Vancomycin-resistant enterococcus (VRE)

POLyPROPyLENE

• Lowest environmental impact of any conventional or

synthetic material

• Offers outstanding fatigue resistance

• Excellent thermal insulating and dielectric properties

• Fire retardant to BS 5867 Part 2 Type C 2008 and NFPA 701

Performance

12

W

E SAVE LIVES

Exclusive importer

Brooklands Medical Supplies LLC

Frank M. Fosco Jr.

Tel: 630-383-9208

frank.fosco@brooklandsmedicalgroup.com

Global hQ: Tyrrelstown Centre, Tyrrelstown, Dublin 15, Republic of ireland

Tel: +353 1 430 3451 · Email: info@brooklandsmedicalgroup.com

References:

1. Research 1. Service (F.T., R.B., M.J.P.), the infection Control Department (E.C.E., C.J.D), and the Geriatric Research Education and Clinical Center (C.J.D.), Cleveland Veterans Affairs Medical Center, Cleveland, Ohio2. Report No.: 2. Fh/REP/116479/3a . Evaluation of surfaces for their growth inhibition of methicillin resistant staphylococcus aureus (mrsa), vancomycin resistant enterococcus faecium (vre) & escherichia coli

using the modified Kirby Bauer test. wPRef.:hygiene/2009/Contract/Disposable Cubicle Curtains/Kirby Bauer *Due to the nature of country specific regulatory systems some BMS products are awaiting the necessary approvals.

BROOKLANDS MEDICAL SUPPLIESTotal Infection Control

Please contact:

BROOKLANDS MEDICAL SUPPLIESTotal Infection Control